Review
Accepted on 27 Jun 2025
The Immune Microenvironment in Endometrial Carcinoma: Mechanisms and
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1586315
- 195 views
Type at least 3 characters
44,917 articles
Systematic Review
Accepted on 27 Jun 2025
The effect of co-administration of vitamin E and C supplements on plasma oxidative stress biomarkers and antioxidant capacity: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials with meta-regression
in Nutritional Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1547888
- 160 views
Original Research
Accepted on 27 Jun 2025
SLC2A1 and MPST as diagnostic and prognostic biomarkers of potential endometrial cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1575916
- 178 views
Original Research
Accepted on 27 Jun 2025
Single-Cell and Machine Learning Integration Reveals Ferroptosis-Driven Immune Landscapes for Melanoma Stratification
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1624691
- 345 views
Systematic Review
Accepted on 27 Jun 2025
Risk Factors for Mortality in Anti-MDA5 antibody-positive Dermatomyositis with Interstitial Lung Disease: A Systematic Review and Meta-Analysis
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1628748
- 136 views
Original Research
Accepted on 27 Jun 2025
FLAIR hyperintense cortical lesions in myelin oligodendrocyte glycoprotein-associated encephalitis with seizures in children: a retrospective single-centre case series
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563481
- 113 views
Correction
Accepted on 27 Jun 2025
Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
in Antigen Presenting Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1650718
- 122 views
Original Research
Accepted on 27 Jun 2025
Mixed lipopeptide-based mucosal vaccine elicits a long-term bone marrow memory response that is potentially cross-reactive against a broad-spectrum of coronaviruses in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1619882
- 310 views
Original Research
Accepted on 27 Jun 2025
Early In Vivo Target Genes in Human Immune Cells Highlight Vitamin D's Role in Antioxidant Defense
in Nutritional Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1559486
- 122 views
Case Report
Accepted on 27 Jun 2025
Secukinumab-Induced Crohn's Disease in a Psoriasis Patient: A Case Report Highlighting Paradoxical Reactions to IL-17 Inhibition
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1628461
- 229 views
Original Research
Accepted on 27 Jun 2025
Feed Status and Skin Injury Modulate Immunopathology, Global Gene Expression, and Survival in Channel Catfish During Virulent Aeromonas hydrophila Infection
in Comparative Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1642531
- 113 views
General Commentary
Accepted on 27 Jun 2025
Commentary: Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1590342
- 133 views
Original Research
Accepted on 27 Jun 2025
Characterization of Novel Anoikis-Related Genes as Prognostic Biomarkers and Key Determinants of the Immune Microenvironment in Esophageal Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1599171
Original Research
Accepted on 27 Jun 2025
Novel Insights into ORFV B2L DNA Vaccine-Mediated Gut Microbiota Modulation and Immune Augmentation in Rats
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1598969
Original Research
Accepted on 27 Jun 2025
Oncogenic CMTM6 Drives M2a Macrophages Formation and Fuels Cervical Cancer Progression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1621816
Original Research
Accepted on 27 Jun 2025
Metrnl/Meteorin-like/IL-41, a Novel Regulator of Bone Metabolism and Disease Activity in Ankylosing Spondylitis: Based on Multi-omics Analysis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1595181
- 117 views